Senate Appropriations Committee Approves FY2024 Funding for CDMRP
July 28, 2023 Yesterday, by an overwhelming bipartisan vote of 27-1, the Senate Committee on Appropriations approved its version of the fiscal year 2024 Defense Appropriations Act. This legislation provides funding for the Congressionally Directed Medical Research Program (CDMRP) consistent with levels provided in previous years by the Committee. Specifically, the bill provides funding for a number of cancer programs, including breast cancer ($130 million), prostate cancer ($75 million), ovarian cancer ($15 million), and rare...